AnovaOS Network Powered Patient Registry
The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.
Infectious Disease|Neoplasms|Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)|Endocrine, Nutritional and Metabolic Diseases (E00-E89)|Mental and Behavioural Disorders|Diseases of the Nervous System|Diseases of the Eye and Adnexa|Diseases of the Ear and Mastoid Process|Diseases of the Circulatory System|Diseases of the Respiratory System|Diseases of the Digestive System|Diseases of the Skin and Subcutaneous Tissue|Diseases of the Musculoskeletal System and Connective Tissue|Diseases of the Genitourinary System|Pregnancy, Childbirth and the Puerperium|Certain Conditions Originating in the Perinatal Period|Congenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)|Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified|Injury, Poisoning and Certain Other Consequences of External Causes|External Causes of Morbidity and Mortality|Factors Influencing Health Status and Contact With Health Services
Assess Natural history, Assessing natural history, including estimating the magnitude of a problem; determining the underlying incidence or prevalence rate of a condition; examining trends of disease over time; assessing service delivery and identifying groups at high risk; and describing and estimating survival;, 5 years|Assess Clinical, Cost and/or Comparative Effectiveness, Determining clinical effectiveness, cost effectiveness, or comparative effectiveness of a test or a treatment;, 5 years|Assess Safety, Measuring and monitoring safety and harm associated with the use of specific products and treatments, including conducting comparative evaluation of safety and effectiveness;, 5 years|Measuring and/or Improving Quality of Care, Measuring or improving quality of care, including conducting programs to measure and/or improve the practice of medicine and/or public health., 5 years
The AnovaOS™ Network Powered Patient Registry may be used to inform the development and conduct of clinical trials and observational studies designed to better understand, prevent, diagnose, treat, ameliorate or cure disease. The AnovaOS™ Network Powered Patient Registry may additionally be used to expedite identification and recruitment of participants for clinical trials of promising therapeutics and observational studies.